Dr. Spencer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-7772
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Clinical Neurophysiology, 1997 - 1998- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1994 - 1997
Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1993 - 1994
University of Minnesota Medical SchoolClass of 1993
Certifications & Licensure
CA State Medical License 1994 - Present
WA State Medical License 2023 - 2026
OR State Medical License 1999 - 2025- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- RNS® System Pivotal Study Start of enrollment: 2005 Dec 01
Publications & Presentations
PubMed
- Dual Treatment of Refractory Focal Epilepsy and Obsessive-Compulsive Disorder With Intracranial Responsive Neurostimulation.Marissa A Kellogg, Lia D Ernst, David C Spencer, Proleta Datta, Eran Klein
Neurology. Clinical Practice. 2024-08-01 - 7 citationsConcurrent brain-responsive and vagus nerve stimulation for treatment of drug-resistant focal epilepsy.Mesha-Gay Brown, Stefan Sillau, Danielle McDermott, Lia D Ernst, David C Spencer
Epilepsy & Behavior. 2022-04-01 - 11 citationsThe IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma.Anh Huan Vo, Prakash Ambady, David Spencer
Epilepsy & Behavior Reports. 2022-01-01
Press Mentions
OHSU Patient Nearly Seizure-Free After Regenerative Brain Cell TherapyMay 18th, 2023- Interneuron Cell Therapy Results in up to 94% Seizure Reduction in Focal EpilepsyApril 23rd, 2023
- Exciting Early Results with Novel Cell Therapy for Focal EpilepsyApril 21st, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
